Bendroflumethiazide

Land: New Zealand

Sprog: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv bestanddel:

Bendroflumethiazide 2.5mg;  ;  

Tilgængelig fra:

Ipca Pharma (NZ) Pty Limited

INN (International Name):

Bendroflumethiazide 2.5 mg

Dosering:

2.5 mg

Lægemiddelform:

Tablet

Sammensætning:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Enheder i pakken:

Blister pack, PVC/PVDC, 14 tablets

Klasse:

Prescription

Recept type:

Prescription

Fremstillet af:

Ipca Laboratories Limited

Terapeutiske indikationer:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Produkt oversigt:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Autorisation dato:

2006-06-28